189 related articles for article (PubMed ID: 34938791)
1. Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients.
Lin YS; Lin MS; Wu VC; Chen YL; Chang JJ; Chu PH; Lip GYH; Chen MC
Front Cardiovasc Med; 2021; 8():775564. PubMed ID: 34938791
[No Abstract] [Full Text] [Related]
2. Venous Thromboembolism and Critical Limb Events in Patients with Atrial Fibrillation: A Nationwide Population-Based Cohort Study.
Lin MS; Chung CM; Chen MY; Chu PH; Chang ST; Yang TY; Wu VC; Lin WY; Lin YS
Angiology; 2022 May; 73(5):413-421. PubMed ID: 34284641
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromsø study.
Hald EM; Løchen ML; Mathiesen EB; Wilsgaard T; Njølstad I; Brækkan SK; Hansen JB
Res Pract Thromb Haemost; 2020 Aug; 4(6):1004-1012. PubMed ID: 32864551
[TBL] [Abstract][Full Text] [Related]
4. Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism.
Lin YS; Tsai HY; Lin CY; Wu VC; Chen TH; Yang TY; Aboyans V; Chen MC
Glob Heart; 2021 Jun; 16(1):45. PubMed ID: 34211831
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
6. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.
Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS
Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
[TBL] [Abstract][Full Text] [Related]
8. Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population-based cohort study.
Adelborg K; Corraini P; Darvalics B; Frederiksen H; Ording A; Horváth-Puhó E; Rørth M; Sørensen HT
J Thromb Haemost; 2019 Aug; 17(8):1305-1318. PubMed ID: 31054195
[TBL] [Abstract][Full Text] [Related]
9. Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study.
Hald EM; Løchen ML; Lappegård J; Ellingsen TS; Mathiesen EB; Wilsgaard T; Njølstad I; Brækkan SK; Hansen JB
TH Open; 2020 Jul; 4(3):e280-e287. PubMed ID: 33005859
[No Abstract] [Full Text] [Related]
10. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
12. Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study.
Dekkers OM; Horváth-Puhó E; Cannegieter SC; Vandenbroucke JP; Sørensen HT; Jørgensen JO
Eur J Endocrinol; 2017 Jan; 176(1):1-9. PubMed ID: 27697972
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
Yhim HY; Lee J; Kim KH; Kim SA; Lee JY; Hwang HG; Hong J; Lee JO; Bang SM
Thromb Res; 2023 Nov; 231():50-57. PubMed ID: 37804738
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
15. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
[TBL] [Abstract][Full Text] [Related]
16. Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism.
Huerta C; Johansson S; Wallander MA; Rodríguez LA
Thromb J; 2008 Aug; 6():10. PubMed ID: 18706117
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
[TBL] [Abstract][Full Text] [Related]
18. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
Heart Rhythm; 2015 Dec; 12(12):2368-75. PubMed ID: 26164377
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.
Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH
Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Safety and Efficacy of Direct Oral Anticoagulants and Warfarin in Atrial Fibrillation or Venous Thromboembolism in Patients with Renal Impairment: Systematic Review, Meta-Analysis and Network Meta-Analysis.
Wang Z; Xiang Q; Hu K; Zhang X; Xie Q; Liu Z; Cui Y
Am J Cardiovasc Drugs; 2021 Nov; 21(6):643-657. PubMed ID: 33817758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
